Background Non-adherence to inhaled combination therapy (ICT) is a major contributor to poor control in difficult asthma1; however identifying non-adherence in this population is challenging. We have shown that suppression of fractional exhaled nitric oxide (FeNO), following directly observed inhaled corticosteroid can identify non-adherence2; it has previously been suggested that a single high FeNO measurement can identify non-adherence in difficult asthma.
Methods We performed a retrospective analysis of patients attending a difficult asthma clinic between January 2007 and December 2010. Prescription refill data, patient demographics, FeNO and lung function were collated. ICT prescription refill ratio % was calculated as the number of doses refilled/number of doses prescribed over 6 months × 100.1 Non-parametric correlation analysis was performed. Tests for non-adherence defined as ICT prescription refill cut-offs of <80% and <50% were assessed.
Results One hundred and forty-six patients underwent systematic evaluation during the time period. Patient characteristics are displayed in Abstract S10 table 1. FeNO level and ICT prescription refill ratio did not correlate significantly (r=−0.11, p=0.2). For FeNO >45 ppb, there was a trend with ICT prescription refill ratio of <80% (p=0.06); significant in patients not prescribed oral steroids (n=99, p=0.016). No relationship existed between FeNO >100 ppb at both prescription refill ratio cut-offs. Using FeNO >45 ppb to define non-adherence, negative (NPV) and positive predictive values (PPV) were: 66% and 61% for <80% ICT prescription refill ratio; 71% and 33% for <50% prescription refill ratio. Using FeNO >100 ppb, NPV and PPV were: 55% and 52% for <80%; 69% and 32% for <50% prescription refill ratio.
Conclusion While there is a weak relationship between a single point-in-time FeNO measurement and non-adherence to ICT in difficult asthma, this cannot be used as an alternative to our previously described FeNO suppression test.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.